substance use disorders

Behavior, Biology, and Chemistry (BBC) Annual Meeting: Translational Research in Substance Use Disorders

25 March 2023

Texas

About Event

This two-day conference focuses on translational aspects of substance use research among chemists, biologists, and behavioral scientists.

A randomized controlled trial of an intervention to reduce stigma toward people with opioid use disorder among primary care clinicians

Scientific article

11 February 2023

Abstract Background Many primary care clinicians (PCCs) hold stigma toward people with opioid use disorder (OUD), which may be a barrier to care. Few interventions exist to address PCC stigma toward people with OUD. This study examined...

A Conversation About Corruption in Substance Use Disorder Treatment

Video and audio recordings

Elizabeth Saenz, UNODC, presents on the issue of patient abuse and corruption in treatment and provides a call to action on the need to address this problem that spans across countries.

Addictive behaviors and craving during the COVID-19 pandemic of people who have recovered from substance use disorder

Scientific article

https://www.tandfonline.com/doi/full/10.1080/10550887.2020.1856298

Massive open online course for Brazilian healthcare providers working with substance use disorders: Curriculum design

Scientific article

29 July 2020

Abstract Background: Interpersonal and technical skills are required for the care of people living with substance use disorders. Considering the applicability and usability of online courses as continuing professional education initiatives...

Starting the Conversation – Substance Use Disorders and Intimate Partner Violence

25 March 2021

Washington DC

United States

Register now: https://umsystem.zoom.us/webinar/register/WN_HrsigrniS1SD7f6A1EROoA

Thursday, March 25, 2021 01:00 PM (EST, Washington, DC time)

A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy

Scientific article

16 November 2020

Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some argue that over‐medicalization of drug‐related impairment lowers prognostic optimism and reduces personal agency.

Principles of Care for Young Adults With Substance Use Disorders

Scientific article

Researchers from the Grayken Center for Addiction at Boston Medical Center have published a series of articles in the Pediatrics journal addressing the six principles of care for young adults with substance use disorders. The aim of the...

New Video on Alternatives to Incarceration

Video and audio recordings

7 December 2020

Policies that allow for alternatives to incarceration are a way to link individuals with substance use disorders to supportive treatment and social services. This proven approach increases the number of people in long term recovery and...

Webinar | Building Strength and Resilience during the COVID-19 Pandemic

20 November 2020

Washington, D.C.

United States

Building Strength and Resilience during the COVID-19 Pandemic: A Focus on Parents with Substance Use Disorders and Their Children

A live webinar exploring strategies for building strength and resilience in parents with substance use disorders during this difficult time.

Presenter: Hendrée E Jones, PhD, Executive Director, UNC Horizons, Professor, Department of Obstetrics and Gynecology, University of North Carolina